Mercury II - Compare the Efficacy and Safety of Lipid Lowering Agents Atorvastatin and Simvastatin With Rosuvastatin in High Risk Subjects With Type IIa and IIb Hypercholesterolemia
Clinical trial NCT00654407 · COMPLETED
Trial details
- NCT number
- NCT00654407
- Sponsor
- AstraZeneca
- Status
- COMPLETED
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2001-11-01
- Enrollment
- 4875
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.